investing.comOCT 52 min read$EL

Why is Estee Lauder stock climbing today?

Estee Lauder (EL) stock rose 2.6% in pre-market trading after Barclays upgraded it to Overweight and raised its price target to $108, citing broad recovery and strong Q4 2026 results. The company reported adjusted EPS of $0.39 and revenue of $3.63B, both beating estimates. Barclays highlighted balanced revenue growth and margin expansion potential. Bernstein SocGen maintained a Market Perform rating with a $106 target. The broader market traded modestly lower.

Original reporting

investing.com

Published Oct 5, 2026, 11:02 AM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Oct 5, 2026, 11:30 AM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

AlphAI market briefMarket movers

Primary signal

$EL

Bullish

high confidence

Mentioned

$EL

Relevance

7/10

AlphAI data visualization · based on investing.com

Decision brief

The 30-second read

$ELBullishMed

Why it matters

The upgrade and new target provide a fresh catalyst for short‑term buying interest.

Market read

EL's pre‑market rally reflects immediate market reaction to a fresh analyst upgrade.

What to watch

Broader market weakness could cap upside despite the upgrade.

Relevance 7/10Novelty 7/10Timing: pre‑market today

Background

Estee Lauder reported Q4 FY2026 earnings that beat estimates, prompting analyst upgrades.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$ELBullishHigh confidence

Context

Barclays upgraded EL to Overweight with a new $108 price target, driving a 2.6% pre‑market rise.

Expected impact

upward pressure as investors price in the upgrade and target raise

Evidence & confidence

Analyst upgrade with a concrete price target typically triggers buying interest, especially after a strong earnings beat.

Market effects

Sector

Consumer‑staples sector may benefit from perceived earnings resilience.

Regional

U.S. equity markets see modest lift from the upgrade.

Global

Limited to U.S. investors; modest global effect.

Counterpoint

What could challenge this read

The upgrade may be premature if margin expansion stalls.

Key entities

Analyst
Barclays
Upgraded EL to Overweight and raised price target to $108.
Company
Estee Lauder Companies Inc
Consumer‑staples cosmetics maker reporting strong Q4 results.

Read at source ← All news

OCT 5

$PTCHighAI 8/10

Stocks making the biggest moves premarket: DraftKings, Itau Unibanco, PTC & more

Premarket movers: Brazilian stocks rallied after election results, with EWZ up 12% and Itau Unibanco, Bradesco up 13%. PTC surged 36% after a $22B acquisition deal. Wells Fargo gained 1% post-upgrade. DraftKings rose 5% and Estee Lauder 2.8% on upgrades.

cnbc.com2 min

OCT 5

$ELHigh

Barclays upgrades Estee Lauder stock rating on broad sales growth

Barclays upgraded Estee Lauder (EL) to Overweight, raising its price target to $108. The move follows strong Q4 2026 sales growth across geographies and categories. EL's stock has risen 34% in six months. Analysts cite margin expansion and positive financial trends. Other firms also adjusted targets and ratings.

investing.com2 min

SEP 15

$ELMed

Estee Lauder outlook revised to stable by S&P on deleveraging

S&P Global Ratings revised Estee Lauder's outlook to stable from negative, citing improved operating results and credit metrics. The agency expects adjusted leverage to fall to 1.9x by fiscal 2027, with mid-single-digit revenue growth and expanded EBITDA margins. Cash flows are projected to decline due to restructuring and investments, but the company plans to use cash balances for debt repayment.

investing.com2 min

AUG 28

$ELHighAI 8/10

Estée Lauder (EL)’s China Bet Just Paid Off. Its Makeup Business Still Hasn’t Caught Up

Estée Lauder (EL) reported Q4 net sales of $3.63B, up 6.3%, driven by luxury fragrance and skincare. It forecasted fiscal 2027 adjusted EPS of $3.10-$3.35, above estimates, sending shares up 11% premarket. However, makeup sales were flat, and hair care dropped 1%. The company also reported a $38M tariff-refund benefit and a net loss of $116M, down from $546M a year earlier.

yahoo.com2 min

AUG 28

$ELMedAI 8/10

Estee Lauder vs Nike: One Turnaround Just Proved Itself, the Other Keeps Slipping

Estee Lauder (EL) reported four consecutive earnings beats, raising its fiscal 2027 EPS guidance to $3.10-$3.35. Nike (NKE) guided revenue down, with Greater China down 12% and Converse down 32%. EL's stock rose 10.46% post-earnings, while NKE's turnaround timeline extends. EL's forward P/E is near 32, with a 1.3% yield. NKE offers a 4.3% yield but faces declining revenue.

aol.com3 min

AUG 27

$MRNAHighAI 8/10

3 Stocks Soared, 3 Stocks Slumped

Moderna (MRNA) surged 176.97% to $174.38 after reporting positive trial results for a cancer therapy with Merck (MRK). Estee Lauder (EL) rose 16% to $98.01 with revenue up 6.5% Y/Y. MicroStrategy (MSTR) gained 12.68% as Bitcoin prices rose. Nebius (NBIS) fell 10% after a $4.5B convertible note offering. Seagate (STX) dropped 8% to $832.56.

baystreet.ca2 min